Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1978 Aug;21(2):674–677. doi: 10.1128/iai.21.2.674-677.1978

Cyclophosphamide effects on murine cryptococcosis.

J R Graybill, L Mitchell
PMCID: PMC422048  PMID: 689741

Abstract

BALB/c mice were given cyclophosphamide and challenged with Cryptococcus neoformans. Delayed-type hypersensitivity was transiently depressed, and survival was either unaffected or shortened by cyclophosphamide.

Full text

PDF
677

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balow J. E., Hurley D. L., Fauci A. S. Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations. J Clin Invest. 1975 Jul;56(1):65–70. doi: 10.1172/JCI108080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cozad G. C., Lindsey T. J. Effect of cyclophosphamide on Histoplasma capsulatum infections in mice. Infect Immun. 1974 Feb;9(2):261–265. doi: 10.1128/iai.9.2.261-265.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Diamond R. D., May J. E., Kane M. A., Frank M. M., Bennett J. E. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J Immunol. 1974 Jun;112(6):2260–2270. [PubMed] [Google Scholar]
  4. Finerty J. F., Krehl E. P. Cyclophosphamide pretreatment and protection against malaria. Infect Immun. 1976 Oct;14(4):1103–1105. doi: 10.1128/iai.14.4.1103-1105.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Graybill J. R., Taylor R. L. Host defense in cryptococcosis. I. An in vivo model for evaluating immune response. Int Arch Allergy Appl Immunol. 1978;57(2):101–113. [PubMed] [Google Scholar]
  6. Kerckhaert J. A., Hofhuis F. M., Willers J. M. Influence of cyclophosphamide on delayed hypersensitivity and acquired cellular resistance to Listeria monocytogenes in the mouse. Immunology. 1977 Jun;32(6):1027–1032. [PMC free article] [PubMed] [Google Scholar]
  7. Lagrange P. H., Mackaness G. B., Miller T. E. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med. 1974 Jun 1;139(6):1529–1539. doi: 10.1084/jem.139.6.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Schwartz A., Orbach-Arbouys S., Gershon R. K. Participation of cyclophosphamide-sensitive T cells in graft-vs-host reactions. J Immunol. 1976 Sep;117(3):871–875. [PubMed] [Google Scholar]
  9. Sher N. A., Chaparas S. D., Greenberg L. E., Bernard S. Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice. Infect Immun. 1975 Dec;12(6):1325–1330. doi: 10.1128/iai.12.6.1325-1330.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES